Sign in to view content

High-Dose Anti-VEGF: Cross-Trial Analysis of Different Doses and Antagonists for the Treatment of Diabetic Macular Edema

Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Video
Published 2019

Related

Visual Impact of Central Subfield Thickness (CST) Fluctuation in Patients With nAMD Treated With Anti-VEGFs in VIEW Trials
Dilsher S. Dhoot, MD
On Demand Cases, Courses, and Papers
2021
Multicenter, Head-to-Head, Real-World Validation Study of Artificial Intelligence Diabetic Retinopathy Screening Systems (AIDRSS)
Aaron Y Lee, MD, MSCI
Annual Meeting Talks
2020
Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2016

Category: Diabetic Retinopathy

See more